chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left forehead feeling different; Heart beat feeling fast; tongue and jaw numb feels like dental anesthesia; My left hand feel cold; This is a spontaneous report from contactable other healthcare professional. A 39-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0217) via an intramuscular route of administration in the left arm on 19Oct2021 at 14:00 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history was not provided and the patient was allergic to unspecified antibiotic and developed a rash. It was unknown whether the patient was diagnosed with COVID-19, prior to the vaccination. It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. Concomitant medications were not provided. On 19Oct2021 at 15:24 via phone call, notified by an employee that the patient had gradually had symptoms after the first dose of COVID-19 vaccine, which was administered on 19Oct2021 at 14:00, symptoms tongue and jaw numb, felt like dental anaesthesia and also felt left hand cold. On the same day, at 16:00 the patient experienced a heartbeat felt fast and left forehead felt different and the patient denies of breathing difficulty or swelling of mouth or tongue. The patient was advised to be immediately evaluated at the nearest emergency room or urgent care. The events resulted in the emergency room/department or urgent care. It was unknown any, therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tongue and jaw numb felt like dental anaesthesia, left hand felt cold, left forehead felt different and the heartbeat felt fast were unknown at the time of this report.
For 1st shot given on 4/17/21, I received the Pfizer shot but for the 2nd shot, on adverse event (5/8/21), I decided to go somewhere closer to home and I was given the Moderna shot, even though it was on 3 separate forms of what shot I should get (initial online form, written form given before getting the shot, and on my covid-19 vaccination record card).
Lots of pain in lymph nodes and golf ball size lump. Motrin and monitored herself.
7:30pm,  3/8/21, fever began,  extreme chills, hands shaking,  can't get warm. Left work went home,during the night fever rose to 103.  Chills,cough,  rapid heart beat. 3/9/21, fever persist,but lower 101. Chills and disorientation persisted.  3/10/21 fever down to normal feeling better but lethargic.  Next vaccine scheduled 4/5/21.I don't want to go.  Please advise what I should do regarding next vaccine?
Approximately at 2pm on 1/21/2021 (7 hours after injection) mild headache/body aches. Approximately 2am 01/22/2021, extreme fatigue/body aches, worsening headache and vertigo. Ibuprofen decreased body ache and headache pain, but not vertigo. Symptoms were resolved by 9pm 01/22/2021.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 17-JAN-2013 at 07:45, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 14-25 hours. On 30-JAN-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to -14C for am estimated total time out of range of 10.5 hours. On 04-MAR-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to exact time not recorded, not as equal to or > 12C for an estimated total time out of range of 10.5 hours. On 12-MAR-2013 at 17:00, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 9.25 hours. On 13-MAR-2013 at 18:00, ZOSTAVAX lot # H019999 was exposed to -14C for an estimated total time out of range of 10.5 hours. On 15-MAR-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not reported) (Lot number H019999). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
Cellulitis according to PCP. Redness on arm adjacent to injection site. 7 days of cephalexin and cotrimoxazole.
Arm ached first at  about 1:00 then at 3:00 started feeling ?yucky? and chills . Lasted all night and next still sick and shaky.
Information has been received from a registered nurse concerning a 17 year old female, who, on an unspecified date, was vaccinated with a first dose of Gardasil.  Subsequently, she developed a little bit of redness and swelling.  On 07-AUG-2007 the patient was vaccinated with a second dose of Gardasil.  Immediately following the vaccination the patient began to swell from the elbow to the shoulder.  The patient felt nauseated and faint.  The patient was treated with BENADRYL.  The patient sought unspecified medical attention.  At the time of the report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested. Initial and follow-up information has been received from a registered nurse concerning a 17 year old female, who, on an unspecified date, was vaccinated with a first dose of GARDASIL. Subsequently, she developed a little bit of a reddness and swelling. On 07-Aug-2007 the patient was vaccinated with a second dose of GARDASIL. Immediately following the vaccination the patient began to swell from the elbow to the shoulder. The patient felt nauseated and faint. The patient was treated with BENADRYL. The patient sought unspecified medical attention. At the time of the report, the patient was "doing wwell." No product quality complaint was involved. Additional information is not expected.
received both Shingrix vaccines, shingles/ suspected vaccination failure; shingles/ Shingles 4-6 times a year; painful; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 74-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (got shingles 4 to 6 times a year, each debilitating).   On an unknown date, the patient received the 1st dose of Shingrix. On 3rd December 2018, the patient received the 2nd dose of Shingrix. On 20th July 2021, unknown after receiving Shingrix and 960 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient received both the doses of Shingrix and still got shingles. The patient stated that the shingles she got in July 2021 were more painful which were along the right side of his/her neck moving to behind right ear. The patient also had mild symptoms in September 2021, refer case US2021AMR208041. The patient asked if GSK working on any booster option. This case was considered as suspected vaccination failure as details regarding laboratory test confirming herpes zoster were unknown at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR208041:same reporter
tidiness of chest; headache; tired; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I am very itchy; Have a lump on my left clavical; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 46-year-old non pregnant female patient received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0178) via an unspecified route of administration on 08Jun2021 16:30 (age at vaccination 46 years) as dose number unknown, single for COVID-19 immunization. The patient medical history was reported as none. The patient's concomitant medications were not reported. Facility where the most recent COVID-19 vaccine administered was reported as Pharmacy or Drug Store. The patient had no known drug allergies. The patient did not receive any other vaccine in four weeks. Covid prior vaccination was unknown and covid tested post vaccination was reported as no. On 09Jun2021 16:00, patient experienced she was very itchy and have a lump on her left clavical. The patient did not receive any treatment for adverse events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
When I was given my second shot I was not given it IM Like it?s supposed to be given, instead I was given it Subq on the very far side of my arm close to my armpit. I now have a red painful patch adjacent to the vaccine site. The pharmacy has apologized and said they have opened an incident report (I?m not sure with who) but I want to make sure it?s reported here bc now I don't know if my vaccine is even effective and this isn't exactly the experience I expected on a vaccine that I've been hesitant on from the beginning . They are monitoring my arm and if it spreads I have to go to the doctors to have it checked
Severe pain and burning in right arm immediately after injection, prolonged numbness and tingling progressing from right arm into neck and right face, migraine without relief since injection, muscle spasms bilateral lower extremities.
Case number PHEH2014US018695, is an initial spontaneous report received from a consumer on 16 Sep 2014 and with a follow up information received from the physician on 10 Nov 2014. This report refers to a 38 years old female patient. Her medical history included allergic to neomycin. Her concomitant medications were not reported. She was vaccinated with FLUVIRIN (batch number: 1412201) intramuscularly at a dose of 0.5 ml in right deltoid on 09 Sep 2014 at 11.30 AM. On 10 Sep 2014, in morning she presented with two hives inferior to the injection site on either side lasted for 3 days. The physician reported that he had no information that the patient had reaction with vaccine. The final outcome of the event was reported as unknown. The seriousness and causality of the events were not reported. Follow up information received from the physician on 10 Nov 2014: Removed another suspect vaccine (FLUCELVAX). Updated batch number of FLUVIRIN, dose, and site of vaccination and physician comment in the narrative.
blisters along her upper lip; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: LIP BLISTER (non-serious), outcome "unknown", described as "blisters along her upper lip".  Additional information: Consumer said she received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on Wednesday. Afterwards, she started to develop blisters along her upper lip. She wants to know if she should do anything to treat it, if this is a common reaction to the vaccine, and if she should still receive the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patients arms was sore 8/18. 8/19 she woke up at 7:45am and was extremely nauseated and was having chills. Patient took some Tylenol regular strength for the pain in her arm. I called patient at 1:43pm to check on patient and the chills had subsided. She was still having nausea.
sinus congestion, headache, cough, post nasal drainage, ear fullness, sneezing, itchy eyes. starting on 8/16/2021
pale,unresponsive,change in breathing pattern;resolved spontaneously p/5mins;
Fever on 3/11 and 3/12/21; body aches; fatigue.   Back to no symptoms by 3/13/21
Hemorrhagic stroke on Nov 2,2022, no symptoms, ICU for 6 days, on-site rehab facility 15 days, home healthcare 6 weeks, currently in out patient physical therapy.  Currently working on right arm and right leg.
Area of cellulitis/blistering on underside of Rt upper arm following VARIVAX given 9/17/08. No fever. Lesion 10.5 cm x 10cm - red, indurated with open blister. Serologic culture done.
low grade fever even with ibuprofen; Severe Chills; trembling; muscle aches; Ocular headache; spasms all over; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-years-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration, administered in left arm on 12Jan2021 at 09:00 hours as dose 1, single (at the age of 38-years-old) for COVID-19 immunisation and received other unspecified vaccine (formulation: unknown, Batch/Lot number and Expiration date was not reported) via an unspecified route of administration, administered in left deltoid on 29Jan2021 as dose 2, single (at the age of 38-years-old) for an unknown indication. Patient had no medical history and known allergies. The patient concomitant medications were not reported. Patient had no other vaccine in four weeks. Patient was not diagnosed with COVID-19, prior to vaccination and had not been tested for COVID-19, post vaccination. On 30Jan2021, at 03:00 hours, patient experienced severe chills, trembling, muscle aches, spasms all over, ocular headache and low-grade fever even with ibuprofen. Patient received ibuprofen as treatment for low-grade fever and no treatment for rest of the events. The outcome of all the events was recovered on an unspecified date of 2021.  Information about lot/ batch number has been requested. Follow-up attempts completed. No further information expected.
This spontaneous report has been received from a consumer via social media, regarding multiples unspecified female patients. The patients had no medical history, concomitant medications, drug reactions/allergies or concurrent conditions. On unknown dates, the patients were vaccinated with a dose GARDASIL injection, (dose, frequency, route, lot number and expiration date were not provided), for prophylaxis. On unknown dates, the patients passed out (syncope), felt dizzy and light headed (dizziness), felt floaters in their eyes (eye disorder), did not feel well (malaise), felt really tired and exhausted all the time (fatigue) and after the vaccination, the patients sought medical attention with multiples doctors and specialist, and as a result, the patients underwent some unspecified laboratories in which the result showed that the patient had some type of infection that their bodies was trying to fight off (infection). Furthermore, it was also reported that some additional unspecified laboratories that were performed to the patients, had results that were coming back to normal, however, it was stated that the patients were still feeling really tired and sick all the time. At the time of reporting, the outcome of syncope, eye disorder, malaise, fatigue and dizziness was unknown. The outcome of infection was reported as recovering. The reporter considered dizziness, eye disorder, syncope, malaise, fatigue and infection to be related to GARDASIL. This is one of two reports from the same reporter. Sender's Comments: US-009507513-1804USA009584.
Great difficulty breathing for approx. 18 hours. Extreme pain in rib cage, headache and dull pain in all limbs. Experienced overwhelming sleepiness.
Extreme pain at injection site(but NO swelling or redness), inability to lift arm from shoulder due to weakness in limb.  Feverishness, nausea, some fatigue
Before i arrived at the waiting area, which had no attendant on duty though intake personnel were within sight range, i had an extreme pressure sensation on the right side of my head.   I lessened the effect by holding my nostrils and blowing when reminded to do so by my husband when i returned to the car after 15 minutes.    Sensations that reminded of bugs crawling beneath my scalp began shortly thereafter, and continue to a lesser degree to this day.    I had lethargy, fatigue and brain fog.until Wednesday.    My right eye remains challenged as i do have an ongoing eyelid issue for the last 8 years.    No arm soreness.
Sore arm, possible ache in shoulder area, achy legs (my usual negative reaction to Rx), fatigue. Sore arm ceased 11/19/2017.
Dose #1: Pfizer/ Dose #2: Pfizer/ Dose #3: Pfizer/ Dose #4: Unknown/ Dose #5: Moderna; COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 09Feb2021 as dose 1, single (Lot number: EN6201), on 02Mar2021 as dose 2, single (Lot number: EN6200) and on 06Nov2021 as dose 3 (booster), single (Lot number: FF2593) at the age of 66 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 29Sep2022 as dose 5 (booster), single (Lot number: 030622B) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), on 02Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "gastric reflux" (unspecified if ongoing); "Hx of blood clots" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "not recovered", described as "Dose #1: Pfizer/ Dose #2: Pfizer/ Dose #3: Pfizer/ Dose #4: Unknown/ Dose #5: Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07Feb2023) Positive; (11Feb2023) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Treatment of paxlovid from 27Jan2023 to 01Feb2023.
she received the 2nd dose on 24Feb2021 and both ofher legs are swollen; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program.   A female patient of an unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on 24Feb2021 as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medication included warfarin taken for an unspecified indication from an unspecified start date and ongoing. Patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot number was not reported), via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. Reporter stated that she received the 2nd dose on 24Feb2021, and both of her legs were swollen. She mentioned that she was taking Warfarin every day. The outcome of event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
2 months after second shot, I had been taken to the emergency room with  subdural hemmorage, stroke, subrachnid hemmorage, leukocytosis, cerebral venous sinus thrombosis.  I would like to find out if this is related to the vaccine.
With 15 minutes of first dose patient experienced dizziness, blurred vision, face swelling and extreme fatigue. These symptoms subsided and the patient slept. The following day patient woke up with a 8 pain scale neck pain, stiffness and some head pain in the back of the skull, and arm soreness. Patient focused on hydration and rest. Today (02/12/2021) neck pain and stiffness has persisted, with slight headache on the back of the head. Reduced to a 4 pain scale.  Overtime patient has also consistently experienced low-appetite, and fatigue. Patient is looking to understand why these symptoms have persisted, and how it can be resolved.
Hep A dose #2/2 was given too early.  It was due March 1st, 2023 and given 2/15/2023.  Pt notified while in clinic of the error and understands he will need to repeat the dose 8/15/2023 or later to be a valid dose.  Pt verbalizes understanding.
Mom refused 3rd dose - states first two doses of Rotateq caused pt diarrhea and cramps x 5 days
Low grade fever, fatigue, sore arm, muscle pain the night of the injection as well as the following day
headache; feeling unwell; fever; chills; cold symptoms and nose keeps swelling up with snot; mucus at back of throat; mucus at back of throat and nose"; This is a spontaneous report from a contactable consumer (Patient). A 66-years-old female patient received second dose bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), via an unspecified route of administration on 06Mar2021 (Age at Vaccination 66-year-old) as 2nd dose, single dose for covid-19 immunisation. Medical history included anaphylactic reaction from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Historical vaccine included first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation.  On 08Mar2021, the patient experienced yesterday some headache; feeling unwell; fever; chills and today cold symptoms and her "nose keeps swelling up with snot" or "mucus at back of throat and nose". Reporter is asking if these symptoms are part of the vaccine, she had an anaphylactic reaction to some medicine before, but this was different. She mentioned is worried about the different mask legislation of states. She seeking information on the need to continue using mask even after vaccination. The outcome of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This case was reported by a healthcare professional and described the occurrence of injection site pruritus in a female subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). On 1 October 2008, the subject received a dose of FLULAVAL at 0.5 ml. At an unknown time after vaccination with FLULAVAL, the subject experienced injection site pruritus. Later, the itching spread to her arms and legs. She also developed an injection site rash and then a maculopapular rash spread to her arms and legs. The itching was in the same areas as the rash. At the time of reporting, the outcome of the events was not known. Follow-up information received on 19 December 2008 via the initial reporter, indicated that there is no further information to provide concerning the reported events.
Fatigue, body aches, sneezing, runny nose, burning nostrils, some dizziness for 3 weeks after the 3rd shot. Had full dose due to cancer treatment in 2020. Last night woke up with bad chills followed by profuse coughing until I woke up and today no symptoms. Was I over vaccinated or pass a blood clot in my sleep? Tested weekly for Covid and all were negative.